UK NICE recommends GSK’s Dostarlimab regimen for womb cancer
This recommendation, part of NICE’s final draft guidance, could potentially benefit nearly 540 adults. A monoclonal antibody, Dostarlimab works by aiding the immune system in combating cancer. Administered